维普中文期刊产品整合服务
8篇 您的检索式:作者名="Offersen B V"
    题名 作者 年代 出处 被引量
1Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer:relation to prognosis and angiogenesis显示文摘Offersen B V Pfeiffer P Andreasen P 2007Lung Cancer2007,56,1:1
2Matrix metallopro- teinase-9measured in urine from bladder cancer patients is an inde- pendent prognostic marker of poor survival显示文摘Offersen B V Knap M M Horsman M R 2010Acta Oncol2010,49,8:1
3Quantifica- tion of angiogenesis as a prognostic marker in human carcino- mas: a critical evaluation of histopathological methods for estimation of vascular density显示文摘OFFERSEN B V BORRE M OVERGAARD J 2003Eur J Cancer2003,39,7:1
4The myofibroblast is the predominant plasminogen activator in- hibitor expressing cell type in human breast carcinomas显示文摘OFFERSEN B V NIELSEN B S HANSEN H G 2003Am J Pathol2003,163,5:1
5Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis显示文摘Offersen B V 2002Br J Cancer2002,87,12:1
6Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer:relation to prognosis and angiogenesia显示文摘Offersen B V Pfeiffer P Andreasen P 0,,01:1
7Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review显示文摘Offersen B V Overgaard M Kroman N 2009Radiother On- col2009,90,1:1
8Patterns of angiogenesis in nonsmall-cell lung carcinoma显示文摘Offersen B V Pfeiffer P Hamilton-Dutoit S 2001Cancer2001,91,8:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费